ACTIVE

BE Pharma Management

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

45 k €

+51.6% YoY

Gross margin

87,8 k €

+37.2% YoY

Equity

194,4 k €

+30.1% YoY

What does BE Pharma Management do?

BE Pharma Management is a Private limited company incorporated in 2015. Its main activity is: Management consultancy activities. Its registered office is in Puurs-Sint-Amands.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0630.764.571

Incorporation

21/05/2015

Legal form

Private limited company

Registered office

G. Gezellelaan 37
2870 Puurs-Sint-Amands · FlandreSee on map

Contributed capital

118 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 46190Agents involved in the sale of a variety of goods 46190Agents involved in the sale of a variety of goods 68100Buying and selling of own real estate 68110Buying and selling of own real estate

Contacts

1 public detail availableLog in to view

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 10 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016
Income statement
Gross margin	87,8 k €	+37.2%	64 k €	+119%	29,2 k €	+4.8%	27,9 k €	+28.7%	21,7 k €	-26.2%	29,4 k €	-25.5%	39,4 k €	+197%	13,3 k €	-58.5%	32 k €	-31.2%	46,4 k €
EBITDA	83,5 k €	+38.9%	60,1 k €	+136%	25,4 k €	+5.0%	24,2 k €	+32.4%	18,3 k €	-29.0%	25,8 k €	-26.0%	34,8 k €	+233%	10,4 k €	-64.6%	29,5 k €	-14.5%	34,5 k €
Operating result	73,8 k €	+37.9%	53,5 k €	+331%	12,4 k €	+15.2%	10,8 k €	+146%	4,4 k €	-61.5%	11,4 k €	-43.2%	20,1 k €	+35697%	56,1 €	-99.7%	18,2 k €	-14.5%	21,3 k €
Net result	45 k €	+51.6%	29,7 k €	+2481%	1,1 k €	-50.1%	2,3 k €	+157%	-4,1 k €	-254%	2,6 k €	-59.5%	6,5 k €	+152%	-12,7 k €	-393%	4,3 k €	+410%	847,6 €
Balance sheet
Equity	194,4 k €	+30.1%	149,4 k €	+24.8%	119,7 k €	+1.0%	118,5 k €	+2.0%	116,2 k €	-3.4%	120,3 k €	+2.2%	117,6 k €	+5.9%	111,1 k €	-10.2%	123,8 k €	+3.6%	119,4 k €
Total assets	492,3 k €	+20.1%	410 k €	-0.9%	413,6 k €	+2.9%	402,1 k €	-6.0%	427,5 k €	-0.9%	431,2 k €	+0.6%	428,5 k €	+6.7%	401,7 k €	-1.3%	406,9 k €	+3.3%	393,9 k €
Cash	6,9 k €	+41.7%	4,9 k €	+241%	1,4 k €	-70.4%	4,8 k €	+6.9%	4,5 k €	-51.7%	9,3 k €	+248%	2,7 k €	+44.2%	1,9 k €	-60.2%	4,7 k €	+32.0%	3,5 k €
Debts	290 k €	+15.0%	252,1 k €	-12.2%	287,3 k €	+3.1%	278,8 k €	-9.1%	306,7 k €	+0.1%	306,2 k €	+1.1%	303 k €	+6.8%	283,8 k €	+2.6%	276,5 k €	+4.8%	264 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Bart Van Herrewegen

Director · since 01 octobre 2025

Active

Eveline Van Hemelrijk

Manager · since 01 juin 2015

Active

Ended mandates

Eveline Van Hemelrijk

Director · since 27 juin 2019

Ended

Eveline Van Hemelrijk

Manager · since 27 juin 2019

Ended

Eveline Van Hemelrijk

Director · since 01 juin 2015

Ended

Eveline Van Hemelrijk

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
APOTHEEK VAN HEMELRIJK● Active	0478.231.576

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/07/2026	17/07/2025	19/07/2024	29/08/2023	20/07/2022	26/07/2021
General meeting	20/05/2026	20/05/2025	21/05/2024	20/05/2023	20/05/2022	20/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

10 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/05/2026	16/07/2026	Dutch	PDF
Abridged model	31/12/2024	20/05/2025	17/07/2025	Dutch	PDF
Abridged model	31/12/2023	21/05/2024	19/07/2024	Dutch	PDF
Abridged model	31/12/2022	20/05/2023	29/08/2023	Dutch	PDF
Micro model	31/12/2021	20/05/2022	20/07/2022	Dutch	PDF
Micro model	31/12/2020	20/05/2021	26/07/2021	Dutch	PDF
Micro model	31/12/2019	29/07/2020	07/10/2020	Dutch	PDF
Micro model	31/12/2018	20/05/2019	31/07/2019	Dutch	PDF
Micro model	31/12/2017	22/05/2018	06/07/2018	Dutch	PDF
Abridged model	31/12/2016	20/05/2017	20/06/2017	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Bart Van Herrewegen

Director · since 01 octobre 2025

Active

Eveline Van Hemelrijk

Manager · since 01 juin 2015

Active

Ended mandates

Eveline Van Hemelrijk

Director · since 27 juin 2019

Ended

Eveline Van Hemelrijk

Manager · since 27 juin 2019

Ended

Eveline Van Hemelrijk

Director · since 01 juin 2015

Ended

Eveline Van Hemelrijk

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates02/10/2025
Benoeming bestuurder
PDF
Mandates05/07/2019
WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Registered office14/09/2015
MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
PDF
Other26/05/2015
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202545 k €↑
2024
Annual accounts 202429,7 k €↑
2023
Annual accounts 20231,1 k €↓
2022
Annual accounts 20222,3 k €↑
2021
Annual accounts 2021-4,1 k €↓
2020
Annual accounts 20202,6 k €↓
2019
Annual accounts 20196,5 k €↑
2018
Annual accounts 2018-12,7 k €↓
2018
Name changeBE Pharma Management
2017
Annual accounts 20174,3 k €↑
2016
Annual accounts 2016847,6 €
2016
Name changeBE PHARMA PUURS
21/05/2015
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BE Pharma Management

Overview

What does BE Pharma Management do?

Trend over 10 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline